Delivery Order SPE2DB25D3404-SPE2DB26FULYA
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,966.31 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 97-103 mg tablets (60-count unit) on September 29, 2025, with completion scheduled for September 30, 2025. This is a firm fixed-price, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count) valued at $1,892.53, with completion scheduled for November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $6,183.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 49-51 mg tablets (60-count supply) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under...
- The Defense Logistics Agency awarded a $44,508.93 delivery order to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 49-51 mg tablets (180-count supply) under a firm fixed price contract structure. The award was issued on September 5, 2025, with an ultimate completion date of September 8, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,224.86 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count) on October 28, 2025, with completion targeted for October 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.45 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) on November 4, 2025, with completion expected by November 5, 2025. This competitively awarded, non-set-aside contract features firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for 90 tablets of Diovan HCT 160-12.5 mg, a combination antihypertensive medication. The contract is valued at $8,328.95 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded with no set-aside designation and represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,550.16 by the Defense Logistics Agency on November 4, 2025, with completion scheduled for November 5, 2025. The delivery order, designated as AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S, pertains to pharmaceutical products and represents a firm fixed-price, competitively awarded contract with no set-aside designation. This award is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Valsartan-HCT 320-25 mg tablets in a 90-count supply. The contract is valued at $3,709.25 and operates under a firm fixed-price delivery order structure with an ultimate completion date of July 22, 2025. This award represents a non-set-aside, competitively awarded contract, demonstrating the vendor's continued capability...